Table_1_A Novel Defined Risk Signature of the Ferroptosis-Related Genes for Predicting the Prognosis of Ovarian Cancer.XLSX
Ferroptosis is an iron-dependent, regulated form of cell death, and the process is complex, consisting of a variety of metabolites and biological molecules. Ovarian cancer (OC) is a highly malignant gynecologic tumor with a poor survival rate. However, the predictive role of ferroptosis-related genes in ovarian cancer prognosis remains unknown. In this study, we demonstrated that the 57 ferroptosis-related genes were expressed differently between ovarian cancer and normal ovarian tissue, and based on these genes, all OC cases can be well divided into 2 subgroups by applying consensus clustering. We utilized the least absolute shrinkage and selection operator (LASSO) cox regression model to develop a multigene risk signature from the TCGA cohort and then validated it in an OC cohort from the GEO database. A 5-gene signature was built and reveals a favorable predictive efficacy in both TCGA and GEO cohort (P < 0.001 and P = 0.03). The GO and KEGG analysis revealed that the differentially expressed genes (DEGs) between the low- and high-risk subgroup divided by our risk model were associated with tumor immunity, and lower immune status in the high-risk group was discovered. In conclusion, ferroptosis-related genes are vital factors predicting the prognosis of OC and could be a novel potential treatment target.
History
References
- https://doi.org//10.1038/onc.2017.11
- https://doi.org//10.1016/j.chembiol.2020.03.014
- https://doi.org//10.1042/BST0340223
- https://doi.org//10.1158/0008-5472.CAN-05-1489
- https://doi.org//10.1186/s13045-018-0605-5
- https://doi.org//10.7150/thno.44705
- https://doi.org//10.3389/fcell.2021.637162
- https://doi.org//10.1038/s41556-019-0305-6
- https://doi.org//10.1101/gad.314674.118
- https://doi.org//10.1016/j.cell.2012.03.042
- https://doi.org//10.1007/s12032-014-0015-7
- https://doi.org//10.1038/s41568-019-0149-1
- https://doi.org//10.1074/jbc.M117.814392
- https://doi.org//10.1016/j.fct.2017.11.015
- https://doi.org//10.1158/0008-5472.CAN-04-4267
- https://doi.org//10.1016/j.bbrc.2019.04.101
- https://doi.org//10.1007/s13238-020-00789-5
- https://doi.org//10.1186/s12885-018-4498-z
- https://doi.org//10.1016/S0140-6736(18)32552-2
- https://doi.org//10.1038/s41392-020-00297-2
- https://doi.org//10.1038/s41419-020-2298-2
- https://doi.org//10.1038/s41416-019-0660-x
- https://doi.org//10.1158/0008-5472.CAN-18-3037
- https://doi.org//10.18632/oncotarget.11495
- https://doi.org//10.1038/nrdp.2016.61
- https://doi.org//10.1158/1078-0432.CCR-07-1731
- https://doi.org//10.1186/s13048-020-00681-0
- https://doi.org//10.1016/j.ygyno.2014.03.556
- https://doi.org//10.1080/0284186X.2020.1827157
- https://doi.org//10.1021/acscentsci.7b00589
- https://doi.org//10.1016/j.cell.2017.09.021
- https://doi.org//10.1007/s13311-020-00929-z
- https://doi.org//10.1016/j.redox.2018.11.009
- https://doi.org//10.1038/cdd.2015.158
- https://doi.org//10.1016/j.tcb.2015.10.014
- https://doi.org//10.1002/jcb.27892
- https://doi.org//10.1080/15548627.2018.1503146
- https://doi.org//10.1007/s00404-016-4137-3
- https://doi.org//10.1016/j.cmet.2020.10.011
- https://doi.org//10.1016/j.biopha.2020.110354
